Year |
Citation |
Score |
2018 |
Joseph-Mathurin N, Su Y, Blazey TM, Jasielec M, Vlassenko A, Friedrichsen K, Gordon BA, Hornbeck RC, Cash L, Ances BM, Veale T, Cash DM, Brickman AM, Buckles V, Cairns NJ, et al. Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 669-677. PMID 30417072 DOI: 10.1016/J.Dadm.2018.08.012 |
0.325 |
|
2015 |
Owen CJ, Gordon B, Brier MR, Wang L, Wang Q, Joseph-Mathurin N, Su Y, Vlassenko A, Blazey T, Speidel B, LaMontagne P, Marcus DS, Friedrichsen KA, Hornbeck RC, Jackson K, et al. IC-P-100: The ILP: A new tool for evaluating preclinical Alzheimer's disease using volumetric MRI in a single participant Alzheimer's & Dementia. 11: P68-P68. DOI: 10.1016/J.Jalz.2015.06.121 |
0.309 |
|
2015 |
Joseph-Mathurin N, Su Y, Vlassenko A, Couture L, Blazey T, Friedrichsen KA, Owen CJ, Hornbeck RC, Cash L, Stevenson TA, Ances B, Xiong C, Buckles V, Moulder KL, Morris JC, et al. P3-132: Comparison of cerebral glucose metabolism 18
F-FDG, early frames of 11
C-PiB, and cerebral blood flow 15
O-H2
O in autosomal dominant Alzheimer's disease Alzheimer's & Dementia. 11: P674-P674. DOI: 10.1016/J.Jalz.2015.06.1000 |
0.335 |
|
2015 |
Joseph-Mathurin N, Su Y, Vlassenko A, Jasielec MS, Blazey T, Friedrichsen KA, Owen CJ, Hornbeck RC, Stevenson TA, Cash L, Xiong C, Ringman JM, Brickman AM, Koeppe RA, Ances B, et al. IC-03-02: Early frame of PiB and FDG in autosomal dominant Alzheimer's disease: Similarity, discrepancy, and clinical implication Alzheimer's & Dementia. 11: P8-P9. DOI: 10.1016/J.Jalz.2015.06.013 |
0.329 |
|
2011 |
Su Y, Vlassenko A, Benzinger T, D'Angelo G, Blazey T, Vora S, Morris J, Mintun M. P1-357: FreeSurfer in regional analysis of beta-amyloid deposition with [11C]PIB positron emission tomography Alzheimer's & Dementia. 7: S227-S227. DOI: 10.1016/J.Jalz.2011.05.637 |
0.331 |
|
2010 |
Mintun MA, Vlassenko A, Sheline YI, Morris JC. IC-01-02: Longitudinal PIB PET imaging of the appearance and accumulation of beta-amyloid in cognitively normal middle and late life adults Alzheimer's & Dementia. 6: S2-S2. DOI: 10.1016/J.Jalz.2010.05.008 |
0.338 |
|
Show low-probability matches. |